XML 51 R41.htm IDEA: XBRL DOCUMENT
v3.22.2.2

Segments (Tables) | 9 Months Ended
--- | ---
Sep. 30, 2022
Segment Reporting [Abstract] |
Information by Reportable Segment | Segment Adjusted EBITDA by reportable segment was as follows:
| Three Months Ended September 30, |  | Nine Months Ended September 30,
| 2022 |  | 2021 |  | 2022 |  | 2021
Biopharmaceuticals | $ | (12,417) |  |  | $ | (12,661) |  |  | $ | (35,286) |  |  | $ | (34,055) |
Exemplar | 346 |  |  | 1,617 |  |  | 4,699 |  |  | 5,312 |
Segment Adjusted EBITDA for reportable segments | $ | (12,071) |  |  | $ | (11,044) |  |  | $ | (30,587) |  |  | $ | (28,743) |
Revenues by reportable segment were as follows:
| Three Months Ended September 30, 2022
| Biopharmaceuticals |  | Exemplar |  |  |  | Total
Revenues from external customers | $ | 14,624 |  |  | $ | 2,098 |  |  |  |  | $ | 16,722 |
Intersegment revenues | — |  |  | — |  |  |  |  | — |
Total segment revenues | $ | 14,624 |  |  | $ | 2,098 |  |  |  |  | $ | 16,722 |
| Three Months Ended September 30, 2021
| Biopharmaceuticals |  | Exemplar |  |  |  | Total
Revenues from external customers | $ | 129 |  |  | $ | 3,204 |  |  |  |  | $ | 3,333 |
Intersegment revenues | 1,141 |  |  | — |  |  |  |  | 1,141 |
Total segment revenues | $ | 1,270 |  |  | $ | 3,204 |  |  |  |  | $ | 4,474 |
| Nine Months Ended September 30, 2022
| Biopharmaceuticals |  | Exemplar |  |  |  | Total
Revenues from external customers | $ | 14,778 |  |  | $ | 10,368 |  |  |  |  | $ | 25,146 |
Intersegment revenues | 1,446 |  |  | — |  |  |  |  | 1,446 |
Total segment revenues | $ | 16,224 |  |  | $ | 10,368 |  |  |  |  | $ | 26,592 |
| Nine Months Ended September 30, 2021
| Biopharmaceuticals |  | Exemplar |  |  |  | Total
Revenues from external customers | $ | 723 |  |  | $ | 9,860 |  |  |  |  | $ | 10,583 |
Intersegment revenues | 1,469 |  |  | — |  |  |  |  | 1,469 |
Total segment revenues | $ | 2,192 |  |  | $ | 9,860 |  |  |  |  | $ | 12,052 |
Reconciliation of Operating Profit (Loss) from Segments to Consolidated | The table below reconciles Segment Adjusted EBITDA for reportable segments to consolidated net loss from continuing operations before income taxes:
| Three Months Ended September 30, |  | Nine Months Ended September 30,
| 2022 |  | 2021 |  | 2022 |  | 2021
Segment Adjusted EBITDA for reportable segments | $ | (12,071) |  |  | $ | (11,044) |  |  | $ | (30,587) |  |  | $ | (28,743) |
Remove cash paid for capital expenditures, net of proceeds from sale of assets, and cash paid for investments in affiliates | 641 |  |  | 1,138 |  |  | 1,309 |  |  | 1,673 |
Add recognition of previously deferred revenue associated with upfront and milestone payments | 14,561 |  |  | 1,163 |  |  | 16,007 |  |  | 1,849 |
Other expenses: |  |  |  |  |  |  |
Interest expense | (2,036) |  |  | (4,765) |  |  | (6,137) |  |  | (13,902) |
Depreciation and amortization | (1,717) |  |  | (2,029) |  |  | (5,470) |  |  | (6,174) |
Gain on disposals of assets | — |  |  | (13) |  |  | — |  |  | (6) |
Impairment losses | — |  |  | — |  |  | (1,120) |  |  | (543) |
Stock-based compensation expense | (2,184) |  |  | (2,422) |  |  | (7,987) |  |  | (11,767) |
Adjustment related to accrued bonuses paid in equity awards | — |  |  | — |  |  | 1,698 |  |  | — |
Equity in net gain (loss) of affiliates | 862 |  |  | — |  |  | 861 |  |  | (3) |
Other | — |  |  | (5) |  |  | (105) |  |  | (19) |
Unallocated corporate costs | (5,744) |  |  | (7,166) |  |  | (24,718) |  |  | (24,835) |
Eliminations | (6) |  |  | (1,237) |  |  | (1,549) |  |  | (1,812) |
Consolidated net loss from continuing operations before income taxes | $ | (7,694) |  |  | $ | (26,380) |  |  | $ | (57,798) |  |  | $ | (84,282) |
Reconciliation of Revenue from Segments to Consolidated | The table below reconciles total segment revenues from reportable segments to total consolidated revenues:
| Three Months Ended September 30, |  | Nine Months Ended September 30,
| 2022 |  | 2021 |  | 2022 |  | 2021
Total segment revenues from reportable segments | $ | 16,722 |  |  | $ | 4,474 |  |  | $ | 26,592 |  |  | $ | 12,052 |
Elimination of intersegment revenues | — |  |  | (1,141) |  |  | (1,446) |  |  | (1,469) |
Total consolidated revenues | $ | 16,722 |  |  | $ | 3,333 |  |  | $ | 25,146 |  |  | $ | 10,583 |

X
- Definition Tabular disclosure of the reconciliation of profit (loss) from reportable segments to the consolidated income (loss) before income tax expense (benefit) and discontinued operations. Includes, but is not limited to, reconciliation after income tax if income tax is allocated to the reportable segment. + References Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 280 -SubTopic 10 -Section 50 -Paragraph 31 -URI https://asc.fasb.org/extlink&oid=126901519&loc=d3e8924-108599 Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 280 -SubTopic 10 -Section 50 -Paragraph 30 -Subparagraph (b) -URI https://asc.fasb.org/extlink&oid=126901519&loc=d3e8906-108599 + Details
Name: | us-gaap_ReconciliationOfOperatingProfitLossFromSegmentsToConsolidatedTextBlock
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- Definition Tabular disclosure of all significant reconciling items in the reconciliation of total revenues from reportable segments to the entity's consolidated revenues. + References Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 280 -SubTopic 10 -Section 50 -Paragraph 31 -URI https://asc.fasb.org/extlink&oid=126901519&loc=d3e8924-108599 Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 280 -SubTopic 10 -Section 50 -Paragraph 30 -Subparagraph (a) -URI https://asc.fasb.org/extlink&oid=126901519&loc=d3e8906-108599 + Details
Name: | us-gaap_ReconciliationOfRevenueFromSegmentsToConsolidatedTextBlock
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- Definition Tabular disclosure of the profit or loss and total assets for each reportable segment. An entity discloses certain information on each reportable segment if the amounts (a) are included in the measure of segment profit or loss reviewed by the chief operating decision maker or (b) are otherwise regularly provided to the chief operating decision maker, even if not included in that measure of segment profit or loss. + References Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 280 -SubTopic 10 -Section 50 -Paragraph 22 -URI https://asc.fasb.org/extlink&oid=126901519&loc=d3e8736-108599 Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 280 -SubTopic 10 -Section 50 -Paragraph 25 -URI https://asc.fasb.org/extlink&oid=126901519&loc=d3e8813-108599 Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 350 -SubTopic 20 -Section 50 -Paragraph 1 -URI https://asc.fasb.org/extlink&oid=121556970&loc=d3e13816-109267 Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 280 -SubTopic 10 -Section 50 -Paragraph 30 -URI https://asc.fasb.org/extlink&oid=126901519&loc=d3e8906-108599 + Details
Name: | us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- References No definition available. + Details
Name: | us-gaap_SegmentReportingAbstract
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration